Irrimax Corporation
Michael Gil has a diverse work experience spanning across multiple companies and roles. Michael recently served as the Chief Operating Officer and Executive Vice President at Irrimax Corporation, starting in December 2021 and September 2018 respectively. Prior to this, they worked at Ecolab from 2007 to 2018, holding various positions including Vice President of Marketing, Managing Director of Surgical Europe, Director of Marketing and Business Development, and Area Vice President of Sales. Before Ecolab, they worked at Microtek Medical Holdings, Inc. where they held positions such as Vice President of Sales, Global Business Manager, Marketing Manager Products, Director of M&A, Business Development Specialist, and R&D Project Manager.
Michael Gil obtained a Bachelor of Arts degree in International Business & Finance from Campbell University, completing their studies from 1994 to 1998.
Irrimax Corporation
Irrimax Corporation is focused on treating and preventing infections, reducing healthcare costs, improving patient outcomes and increasing the safety of healthcare professionals.Innovation Technologies, Inc., parent company to Irrimax Corporation, holds the rights to US and worldwide patents that provide broad protection for the use oflow-concentration CHG (1% or less) technology. The company’s flagship product, Irrisept, is jet lavage containing low concentration Chlorhexidine Gluconate (CHG) 0.05% in sterile water for irrigation.Irrimax has attracted experts in the fields of product development, clinical research, manufacturing and distribution. Their management team is committed to leading the organization according to high standards of integrity and accountability. Irrimax Corporation is focused on driving innovation and improving patient outcomes.